Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (τi): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas

被引:23
|
作者
Chawla, S. [1 ]
Loevner, L. A. [1 ]
Kim, S. G. [1 ,5 ]
Hwang, W. -T. [3 ]
Wang, S. [1 ]
Verma, G. [1 ]
Mohan, S. [1 ]
LiVolsi, V. [4 ]
Quon, H. [2 ,6 ]
Poptani, H. [1 ,7 ]
机构
[1] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA
[5] NYU, Dept Radiol, 560 1St Ave, New York, NY 10016 USA
[6] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
[7] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England
基金
美国国家卫生研究院;
关键词
QUANTITATIVE DCE-MRI; BREAST-CANCER; OROPHARYNGEAL CANCER; TREATMENT RESPONSE; PARAMETERS; EXCHANGE; CHEMOTHERAPY; PREDICTION; CERVIX; HPV;
D O I
10.3174/ajnr.A5440
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Shutter-speed model analysis of dynamic contrast-enhanced MR imaging allows estimation of mean intracellular water molecule lifetime (a measure of cellular energy metabolism) and volume transfer constant (a measure of hemodynamics). The purpose of this study was to investigate the prognostic utility of pretreatment mean intracellular water molecule lifetime and volume transfer constant in predicting overall survival in patients with squamous cell carcinomas of the head and neck and to stratify p16-positive patients based upon survival outcome. MATERIALS AND METHODS: A cohort of 60 patients underwent dynamic contrast-enhanced MR imaging before treatment. Median, mean intracellular water molecule lifetime and volume transfer constant values from metastatic nodes were computed from each patient. Kaplan-Meier analyses were performed to associate mean intracellular water molecule lifetime and volume transfer constant and their combination with overall survival for the first 2 years, 5 years, and beyond (median duration, >7 years). RESULTS: By the last date of observation, 18 patients had died, and median follow-up for surviving patients (n = 42) was 8.32 years. Patients with high mean intracellular water molecule lifetime (4 deaths) had significantly (P = .01) prolonged overall survival by 5 years compared with those with low mean intracellular water molecule lifetime (13 deaths). Similarly, patients with high mean intracellular water molecule lifetime (4 deaths) had significantly (P = .006) longer overall survival at long-term duration than those with low mean intracellular water molecule lifetime (14 deaths). However, volume transfer constant was a significant predictor for only the 5-year follow-up period. There was some evidence (P < .10) to suggest that mean intracellular water molecule lifetime and volume transfer constant were associated with overall survival for the first 2 years. Patients with high mean intracellular water molecule lifetime and high volume transfer constant were associated with significantly (P < .01) longer overall survival compared with other groups for all follow-up periods. In addition, p16-positive patients with high mean intracellular water molecule lifetime and high volume transfer constant demonstrated a trend toward the longest overall survival. CONCLUSIONS: A combined analysis of mean intracellular water molecule lifetime and volume transfer constant provided the best model to predict overall survival in patients with squamous cell carcinomas of the head and neck.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 50 条
  • [1] Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck
    Kim, Sungheon
    Quon, Harry
    Loevner, Laurie A.
    Rosen, Mark A.
    Dougherty, Lawrence
    Kilger, Alex M.
    Glickson, Jerry D.
    Poptani, Harish
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2007, 26 (06) : 1607 - 1617
  • [2] Pretreatment Diffusion-Weighted and Dynamic Contrast-Enhanced MRI for Prediction of Local Treatment Response in Squamous Cell Carcinomas of the Head and Neck
    Chawla, Sanjeev
    Kim, Sungheon
    Dougherty, Lawrence
    Wang, Sumei
    Loevner, Laurie A.
    Quon, Harry
    Poptani, Harish
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 200 (01) : 35 - 43
  • [3] Dynamic contrast-enhanced MRI and Doppler sonography in patients with squamous cell carcinoma of head and neck treated with induction chemotherapy
    Chawla, Sanjeev
    Loevner, Laurie
    Mohan, Suyash
    Lin, Alexander
    Sehgal, Chandra M.
    Poptani, Harish
    [J]. JOURNAL OF CLINICAL ULTRASOUND, 2022, 50 (09) : 1353 - 1359
  • [4] Preoperative Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas
    Nguyen, T. B.
    Cron, G. O.
    Mercier, J. F.
    Foottit, C.
    Torres, C. H.
    Chakraborty, S.
    Woulfe, J.
    Jansen, G. H.
    Caudrelier, J. M.
    Sinclair, J.
    Hogan, M. J.
    Thornhill, R. E.
    Cameron, I. G.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2015, 36 (01) : 63 - 69
  • [5] Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck
    Asaumi, J
    Yanagi, Y
    Konouchi, H
    Hisatomi, M
    Matsuzaki, H
    Kishi, K
    [J]. ORAL ONCOLOGY, 2004, 40 (06) : 579 - 584
  • [6] Prediction of Disease-Free Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging
    Chawla, S.
    Kim, S.
    Loevner, L. A.
    Hwang, W. -T.
    Weinstein, G.
    Chalian, A.
    Quon, H.
    Poptani, H.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2011, 32 (04) : 778 - 784
  • [7] Prediction of Response to Chemoradiation Therapy in Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging
    Kim, S.
    Loevner, L. A.
    Quon, H.
    Kilger, A.
    Sherman, E.
    Weinstein, G.
    Chalian, A.
    Poptani, H.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (02) : 262 - 268
  • [8] Quantitative parameters correlated well with differentiation of squamous cell carcinoma at head and neck: a study of dynamic contrast-enhanced MRI
    Ji, Xiao Dong
    Yan, Shuo
    Xia, Shuang
    Guo, Yu
    Shen, Wen
    [J]. ACTA RADIOLOGICA, 2019, 60 (08) : 962 - 968
  • [9] Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas
    Le, QT
    Sutphin, PD
    Raychaudhuri, S
    Yu, SCT
    Terris, DJ
    Lin, HS
    Lum, B
    Pinto, HA
    Koong, AC
    Giaccia, AJ
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (01) : 59 - 67
  • [10] The value of dynamic contrast-enhanced MRI in diagnosis of malignant lymphoma of the head and neck
    Asaumi, J
    Yanagi, Y
    Hisatomi, M
    Matsuzaki, H
    Konouchi, H
    Kishi, K
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2003, 48 (02) : 183 - 187